Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06712797 · ClinicalTrials.gov registry record · NA
Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center
A NA study of Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06712797 is a NA study of Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 24 participants, below the 600-participant average among 84 other Pancreatic Ductal Adenocarcinoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06712797, a NA study of Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this Study is to assist in implementing a practical, easy-to-adopt lifestyle intervention that optimizes patient outcomes and minimizes pancreatic ductal adenocarcinoma (PDAC) risk.
Conditions Studied
Interventions
- BEHAVIORAL Physical Activity (PA)
- BEHAVIORAL Nutrition (N)
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-02-19 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06712797
The ClinicalTrials.gov registry entry for NCT06712797 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 600-participant average among 84 other Pancreatic Ductal Adenocarcinoma trials with a reported enrollment target (96% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pancreatic Ductal Adenocarcinoma appearing as the primary indexed condition, and to 2 interventions - of which Physical Activity (PA) is the first listed.
NCT06712797 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06712797 about?
NCT06712797 is a clinical study titled "Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center". The purpose of this Study is to assist in implementing a practical, easy-to-adopt lifestyle intervention that optimizes patient outcomes and minimizes pancreatic ductal adenocarcinoma (PDAC) risk.
What is the current status of trial NCT06712797?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-02-19. Estimated completion is 2027-11.
What conditions does trial NCT06712797 study?
This clinical trial studies the following conditions: Pancreatic Ductal Adenocarcinoma, Intraductal Papillary Mucinous Neoplasm.
What interventions are being tested in trial NCT06712797?
The interventions under investigation include: Physical Activity (PA) (BEHAVIORAL), Nutrition (N) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06712797?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06712797 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Ductal Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
RECRUITING · NA
-
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
RECRUITING · NA
-
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
RECRUITING · Phase 2
-
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
RECRUITING · Phase 1
-
A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy
RECRUITING
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
Explore more on PlainTrial
Pancreatic Ductal Adenocarcinoma
All registered trials for this condition
Intraductal Papillary Mucinous Neoplasm
All registered trials for this condition
Florida
All trials with a study site in Florida
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.